The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
An association exists between respiratory viruses and bacterial infections. Prevention or treatment of the preceding viral infection is a logical goal for reducing this important cause of morbidity and mortality. The ability of the novel, selective parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 to prevent the synergism between a paramyxovirus and Streptococcus pneumoniae was examined in this study. A model of secondary bacterial pneumonia after infection with a recombinant Sendai virus whose hemagglutinin-neuraminidase gene was replaced with that of human parainfluenza virus type 1 [rSV(hHN)] was established in mice. Challenge of mice with a sublethal dose of S. pneumoniae 7 days after a sublethal infection with rSV(hHN) (synergistic group) caused 100% mortality. Bacterial infection preceding viral infection had no effect on survival. The mean bacterial titers in the synergistic group were significantly higher than in mice infected with bacteria only. The virus titers were similar in mice infected with rSV(hHN) alone and in dually infected mice. Intranasal administration of BCX 2798 at 10 mg/kg per day to the synergistic group of mice starting 4 h before virus infection protected 80% of animals from death. This effect was accompanied by a significant reduction in lung viral and bacterial titers. Treatment of mice 24 h after the rSV(hHN) infection showed no protection against synergistic lethality. Together, our results indicate that parainfluenza viruses can prime for secondary bacterial infections. Prophylaxis of parainfluenza virus infections with antivirals might be an effective strategy for prevention of secondary bacterial complications in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382002 · Cited by 916
Oral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711 · cited 1×
“by 44% in influenza-infected children 1 to 12 years old (50).”
BackgroundEtiology of community-acquired pneumonia in 254 hospitalized children
JUVÉN, T., MERTSOLA, J., WARIS, M., LEINONEN, M., MEURMAN, O., ROIVAINEN, M., ESKOLA, J., SAIKKU, P., & RUUSKANEN, O. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200004000-00006 · Cited by 643 · cited 2×
“However, members of the Paramyxoviridae family, particularly respiratory syncytial virus (RSV) and human parainfluenza viruses (hPIVs), have also been implicated in the pathogenesis of bacterial otitis media (5, 20, 21, 41), sinusitis (18), and pneumonia (25, 28).”
BackgroundBenefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484 · cited 1×
“In vaccinated adults, a similar protective effect can be seen against secondary bacterial pneumonia (14, 36, 37 , 38).”
McCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423 · cited 2×
“Thus, in some respects the model is similar to that developed for influenza virus and pneumococcus (32), reinforcing the concept that respiratory viruses other than influenza virus predispose to secondary bacterial infections.”
BackgroundResultSelf-citationHenderson, F. W., Collier, A. M., Sanyal, M. A., Watkins, J. M., Fairclough, D. L., Clyde, W. A., & Denny, F. W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206103062301 · Cited by 393 · cited 2×
“However, members of the Paramyxoviridae family, particularly respiratory syncytial virus (RSV) and human parainfluenza viruses (hPIVs), have also been implicated in the pathogenesis of bacterial otitis media (5, 20, 21, 41), sinusitis (18), and pneumonia (25, 28).”
Background(1998) · The Lancet · doi:10.1016/s0140-6736(98)10190-3 · Cited by 351
Clinical effectiveness of influenza vaccination in Manitoba.
Fedson, D. S. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160074032 · Cited by 278 · cited 1×
“In vaccinated adults, a similar protective effect can be seen against secondary bacterial pneumonia ( 14 , 36, 37, 38).”
Cited by
Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
“However, both Sendai virus and influenza virus, at low doses that induce minimal pathology, can support secondary invasion (5, 104).”
BackgroundSelf-citationThe co-pathogenesis of influenza viruses with bacteria in the lung.
McCullers, J. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3231 · Cited by 722
Self-citationViral and Bacterial Interactions in the Upper Respiratory Tract
Bosch, A. A. T. M., Biesbroek, G., Trzcinski, K., Sanders, E. A. M., & Bogaert, D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003057 · Cited by 651
“NA produced by influenza and para-influenza viruses creates an entry point for bacteria into host cells by cleaving sialic acids residues, thereby exposing bacterial receptors on the surface of the upper respiratory tract [79] [80] [81] .”
BackgroundAvadhanula, V., Rodriguez, C. A., DeVincenzo, J. P., Wang, Y., Webby, R. J., Ulett, G. C., & Adderson, E. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1629-1636.2006 · Cited by 357
Metadata
- Authors
- Alymova, I. V., Portner, A., Takimoto, T., Boyd, K. L., Babu, Y. S., & McCullers, J. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-01
- Volume
- 49
- Issue
- 1
- Pages
- 398-405
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2096613940
- Cited by
- 47
- References
- 8
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae. https://app.cochat.ai/papers/10.1128/aac.49.1.398-405.2005
- The paper
- Alymova, I. V., Portner, A., Takimoto, T., Boyd, K. L., Babu, Y. S., & McCullers, J. A. (2005). The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.49.1.398-405.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.